Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, announced that data from the SENZA Painful Diabetic Neuropathy Randomized Controlled Trial will be presented at the American Diabetes Association 81st Scientific Sessions virtual meeting, June 25-29, 2021.
June 22, 2021
· 8 min read